Longitudinal analysis of antibody decay in convalescent COVID-19 patients
Abstract Determining the sustainability of antibodies targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for predicting immune response against the Coronavirus disease 2019 (COVID-19). To quantify the antibody decay rates among the varying levels of anti-nucleocapsid...
Guardado en:
Autores principales: | Weiming Xia, Mingfei Li, Ying Wang, Lewis E. Kazis, Kim Berlo, Noureddine Melikechi, Gregory R. Chiklis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f32bbc5fac4d4f68be1005417f9bcec9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The concentrated antibody from convalescent plasma balanced the dysfunctional immune responses in patients with critical COVID‐19
por: Mingfeng Liao, et al.
Publicado: (2021) -
Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini M, et al.
Publicado: (2021) -
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy
por: Abhinay Gontu, et al.
Publicado: (2021) -
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
por: Jonathan D. Herman, et al.
Publicado: (2021) -
Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection
por: Margherita Rosati, et al.
Publicado: (2021)